The Role of SN‐38 Exposure, <i>UGT1A1*28</i> Polymorphism, and Baseline Bilirubin Level in Predicting Severe Irinotecan Toxicity
Roshni Ramchandani, Jogarao Gobburu(University of Maryland, Baltimore), Mark J. Ratain(University of Chicago), John R. Johnson(Santa Barbara Museum of Natural History), Atiqur Rahman(Jamia Millia Islamia), Yaning Wang(Yangzhou University), Mehul Mehta(Center for Drug Evaluation and Research), Amna Ibrahim(Beni-Suef University), Brian Booth, Federico Innocenti(AbbVie (United States))
Cited by 84
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
|The Oncologist|2007|1.4k